Abstract
Prescription drug monitoring programs (PDMPs) are primary prevention tools designed to reduce rising rates of substance use disorders (SUD) and sequelae such as neonatal abstinence syndrome. Evidence regarding OB/GYN perceptions of PDMPs, which may impact PDMP utilization, is unavailable. This study examines perceived PDMP effectiveness among OB/GYNs compared to primary care physicians (PCPs).
Original language | American English |
---|---|
Pages (from-to) | 99S-99S |
Journal | Obstetrics and Gynecology |
Volume | 133 |
Issue number | 1 |
DOIs | |
State | Published - May 2019 |